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We have implemented a method that identifies the genomic
origins of sample proteins by scanning their peptide-mass finger-
print against the theoretical translation and proteolytic digest of
an entire genome. Unlike previously reported techniques, this
method requires no predefined ORF or protein annotations. Fixed-
size windows along the genome sequence are scored by an
equation accounting for the number of matching peptides, the
number of missed enzymatic cleavages in each peptide, the num-
ber of in-frame stop codons within a window, the adjacency
between peptides, and duplicate peptide matches. Statistical sig-
nificance of matching regions is assessed by comparing their scores
to scores from windows matching randomly generated mass data.
Tests with samples from Saccharomyces cerevisiae mitochondria
and Escherichia coli have demonstrated the ability to produce
statistically significant identifications, agreeing with two com-
monly used programs, PEPTIDENT and MASCOT, in 86% of samples
analyzed. This genome fingerprint scanning method has the po-
tential to aid in genome annotation, identify proteins for which
annotation is incorrect or missing, and handle cases where se-
quencing errors have caused framing mistakes in the databases. It
might also aid in the identification of proteins in which recoding
events such as frameshifting or stop-codon read-through have
occurred, elucidating alternative translation mechanisms. The pro-
totype is implemented as a clientserver pair, allowing the distri-
bution, among a set of cluster nodes, of a single or multiple
genomes for concurrent analysis.
Peptide mass fingerprinting is a principal protein identifica-tion technique that was introduced in 1993 by several groups
(1–3). Fractions from the separation of a protein sample by
means of 2D gel electrophoresis or multidimensional HPLC are
enzymatically digested and analyzed by MS. The resulting pep-
tide mass fingerprints are matched against a sequence database
to identify the proteins present in the sample. Commonly used
computer programs such as PEPTIDENT (4), PROFOUND (5),
MASCOT (6), and SHERPA (7) match peptide fingerprints by
comparing the masses in the fingerprint to those derived by in
silico digestion of predicted or confirmed database protein
sequences. Misidentified or unidentified ORFs can present a
major challenge to the process, as can sequencing insertion
deletion errors (indels). Furthermore, current methods cannot
readily detect proteins generated by various alternative process-
ing mechanisms observed at each stage of protein production.
Examples include transcriptional slippage (8), alternative splic-
ing (9), internal initiation (10, 11), and recoding (12, 13), the
latter of which includes nonstandard translational phenomena
such as programmed frameshift and stop codon read-through.
Proteins produced by such mechanisms may be absent from a
protein database, leaving no positive search target. A frameshift
product might be incorrectly identified as the in-frame product
(with lower confidence because of no matches past the frame-
shift site), or not at all, because there are too few peptides
matching in the original frame. The normal and transframe
proteins translated from a sequence prone to programmed
frameshift will be identified as only a single product. Without
new search methods, such ‘‘under-identifications’’ may end up
hiding mechanisms of biological significance from researchers.
The present genome-search approach was conceived to aid in
the detection of alternative products among proteins from
mitochondria of Saccharomyces cerevisiae separated by HPLC
and analyzed by electrospray ionization (ESI)-MS of both intact
proteins and their tryptic-digest products (B.M., C. Nelson,
A.A.S., A. J. Baucum, M.C.G., R. Chowdry, J. Simmons, N.
Wills, J. Atkins, and R.G., unpublished work). The genome
fingerprint scanning (GFS) application matches peptide mass
fingerprint data to a genomic locus without reference to ORF,
protein anchor, or other annotation. The entire putative pro-
teome is translated from the full genome sequence and digested
by using the rules for a particular protease. The program matches
masses from the peptide fingerprint to those generated by the in
silico digestion, then scans in windows across the genome to
identify regions where a high density of hits indicates a putative
genomic origin for one of the sample proteins. The process is
summarized in Fig. 1.
The in silico digestion of the raw S. cerevisiae proteome
(translated genome) in all six reading frames using rules for the
enzyme trypsin generates 8.9 million hypothetical peptides. The
profusion of in silico fragments generated by the simulated
digestion of a whole genome results in a large background of
spurious hits against which to discern genuine matches. For
example, in 100 full-genome searches against 40 randomly
generated masses at 0.05% mass tolerance, an average of 145,190
or 1.6% of the S. cerevisiae fragments match in each search,
equivalent to an average of 3,630 fragments per input mass. If
evenly distributed along forward and reverse strands, a hit would
occur every 185 nt. In reality, the hits are unevenly distributed,
forming clusters of varying density determined by factors such as
the location of lysine and arginine-encoding codons across the
genome. In any case, masses from the sample protein invariably
match many regions of the genome in addition to their genomic
origin. Conversely, because of competitive ionization of peptide
species, only a portion of the peptides expected from a given
coding region are observed by means of MS analysis.
The method we have developed appears able to discriminate
real protein hits from the random background when using a loose
match tolerance of 0.05% (500 ppm). Tests with data from liquid
chromatography-separated yeast mitochondrial proteins ana-
lyzed with ESI-MS (Micromass Quattro II, Manchester, U.K.)
and from matrix-assisted laser desorption ionization (MALDI)-
MS analysis of 2D gel-separated Escherichia coli proteins pro-
duced statistically significant identifications (P  0.05), the ma-
jority in agreement with MASCOT or PEPTIDENT.
The GFS method has promise for identifying proteins involv-
ing nonstandard translation and also has potential to be used for
genome annotation based directly on observed proteins (14, 15).
Researchers have also recently developed methods for scanning
raw genomic data by using tandem MS data (16, 17). Tandem MS
involves an additional step where select peptides are introduced
into a collisional unit and bombarded with heavy atoms. The
resulting stepwise fragmentation pattern can be used to recon-
struct the peptide sequence. Although approaches that incor-
porate tandem and higher-order MS are generally agreed to
provide the most authoritative identifications, the analysis of
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spectra can be complicated by posttranslational modifications
(18) or internal (nonterminal) dissociation of peptide bonds
(19). In contrast, peptide mass fingerprinting has the benefit of
simplicity and lower equipment cost. We believe that GFS and
the tandem-MS genome-scanning methods could be used
complementarily to produce a high-confidence, genome-based
characterization of protein samples.
Computational Methods
In silico digestion of an entire genome sequence generates
masses for all peptides that might be produced by its in vivo
translation and subsequent proteolytic digestion. Translation
and digestion are performed in all forward and reverse frames.
The process proceeds from 5 to 3 on each sequence, keeping
an in-process list of not yet terminated fragments and a final
master list of terminated fragments. As each in-frame codon is
encountered the mass of its amino acid translation is added to
each fragment of the in-process list. A new fragment is added to
the incomplete list after each cleavage or stop codon and at each
start codon. Terminated fragments are transferred to the master
list when cleavage sites and stop codons are encountered. Any
fragment falling below a length threshold of three codons is
discarded.
The enzyme trypsin cleaves after lysine and arginine, encoded
by a total of eight codons. In the standard genetic code, the start
codon is ATG (also coding internal methionine) and stop codons
are TAA, TAG, and TGA. For mtDNA, start and stop codons
are ATG, ATA and TAA, TAG, respectively. The system
supports the use of alternative genetic codes by using separate
translation dictionaries, selected by annotation in the FASTA
header of a sequence, and defaulting to standard nuclear
encoding.
Duplicate fragments (produced, e.g., when a start codon
follows a cleavage codon) are prevented by checking a queue
containing fragments recently transferred for any fragment with
the same start codon and mass before transferring the new
fragment to the final digest list. Incomplete proteolytic digestion
of a protein sample results in peptides containing internal
cleavage sites. The presence of such missed cleavages requires
that the in silico digest peptides also contain them. The program
uses the variable b to specify the maximal number of missed
cleavage sites (breaks) allowed internally to a fragment. For
efficiency, b is generally kept low, i.e., b  2.
In silico digestion of the nuclear plus mitochondrial genome of
S. cerevisiae with b  2 generates 8.9 million fragments and
requires 200 MB of memory. The program stores the mass,
start point, length, number of breaks, and reading frame of each
fragment. The computational complexity of the digestion pro-
cess is roughly linear, or O(n), in correspondence to genome size
n. The matching process is O(nm), with m representing the size
of the mass list. Further algorithmic details are provided in
Supporting Text, which is published as supporting information on
the PNAS web site, www.pnas.org.
Mass data from either MALDI-MS or ESI-MS is matched to
the in silico digestion to within a tolerance level calculated as a
percentage of the experimental mass (%). Each matching
fragment is mapped back to its position on the chromosome (Fig.
1). Two scans across each chromosome evaluate match criteria
for windows of size w to identify those with a high score (scoring
discussed below). For all experiments herein w  500. The first
scan scores windows in 100-nt increments, providing an internal
histogram of score distributions used by the program to establish
a cutoff level such that only the top n scoring clusters are
examined on the subsequent scan. Currently, n is fixed at a value
of 10. Regions with windows scoring above the threshold are
examined in further detail by an extension scan used to deter-
mine the full extent of the hit-cluster region. The extension scan
starts with each high-scoring window and proceeds backward in
50-nt steps, considering each window of size w until the score
falls below a defined cutoff. This marks the start of the full
Fig. 1. Illustration of the matching process. Masses derived from MS analysis are matched within a tolerance % against the in silico genome digest. The
matching peptides from the digest are then mapped positionally back onto the chromosome whence they were derived, and clusters are located to determine
protein hits.


















region. A scan forward from the original window in 50-nt steps
again considers windows of size w until the same cutoff is
reached, marking the end of the extended region. The cutoff
currently used is half of the score of the 10th highest-scoring
window found on the initial scan.
Several scoring methods have been investigated. Simple mea-
sures include the total number of hits (matches) per window and
the percentage of the DNA sequence contained within matching
fragments. The former tends to favor regions containing mul-
tiple repeats of a peptide matching one of the input masses and
fails to account for the lower frequency of peptides with missed
cleavages. Sequence coverage scores are inflated by high-mass
fragments. A scoring function was developed to address these
issues. It considers the following aspects of each window of size
w: (i) the number of hits in a single frame; (ii) the number of
possible hits in the same frame (i.e., the total digested fragment
count); (iii) the number of missed cleavages in each fragment;
(iv) the number of in-frame stop codons encountered in the
window before the current fragment; (v) duplicate mass matches;
and (vi) abutment of fragments.
Multiplicative combination of these attributes is important for
scoring features such as the number of preceding stop codons,
missed cleavages, and duplicate fragments matched. For exam-
ple, whereas a region with one in-frame stop may still be
considered because it could be caused by a sequence error or
stop codon read-through (13, 20), multiple in-frame stops are
increasingly unlikely. If the probability of stop-codon present
in-frame is p, then the probability of s occurrences is ps. The
scoring equation does not attempt to model actual probabilities.
The data required to ascertain realistic probabilities or frequen-
cies of these occurrences would be very difficult to obtain.
Instead, the scoring function is intended to maximally discrim-
inate randomly formed clusters from real hits, while allowing for
occurrences such as sequence errors or missed cleavages.
Assignment of penalty values to each of the listed factors
allows their multiplicative combination. The values are: cb,
penalty for missed cleavages, default 0.6; cs, penalty for preced-
ing in-frame stops, default 0.4; cd, penalty for preceding dupli-
cate-mass matches, default 0.6; and ca, penalty for N terminus
not abutting a preceding fragment, default 0.9.
For a window containing t hypothetical fragments, h of which
match experimentally measured peptide masses, we calculate a
window score s by summing the penalty products for each
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The functions b( fj), s( fj), d( fj), and a( fj) return counts for the
number of breaks in a fragment (e.g., Lys and Arg codons), the
number of stops preceding a fragment, the number of other
preceding matches for this mass in the window, and whether or
not (1 or 0) the amino terminus of the fragment abuts a
preceding fragment, respectively. The term t normalizes the
results for the total number of digest fragments in the window,
but used by itself can skew results toward windows with a small
number of possible fragments; h counterbalances this by giving
weight to the number of hits in the window, and is reduced by d,
the number of duplicate matches in the window. Scores are
multiplied by a scaling factor of 100 to simplify the histogram
analysis.
These scores are used to differentiate statistically significant
match regions from the backdrop of random hits. Methods to
assign probability estimators to fingerprint matches have been
described by several groups. One approach is to derive a
probabilistic function describing the likelihoods of alternative
identifications, as was done in PROFOUND (5), or to assign
a probability that a given protein match is by chance as was
done in MASCOT (6). Another is to use randomized data to es-
tablish a baseline for assigning significance to matches with real
data (21).
We use a method similar to the latter, by which we calculate
the significance of a match region as a function of its window
score and the total number of masses in the experimental
spectrum. Each value in a randomly selected subset of a large set
of experimental peptide masses is perturbed by a random
modification representing the addition or subtraction of H, C, O,
and N atoms. A large number of such mass lists is searched
against the genome fragment database, establishing a histogram
to represent the range of the null hypothesis (i.e., that any given
result is caused by chance). The histogram is used to define Ps,
the probability in a single genome scan that a randomly chosen
set of masses, of the same size, would achieve a score equal or
above the score considered (derivation in Supporting Text). The
scoring methods used by GFS and MASCOT cannot be directly
equated because the GFS significance score describes the prob-
ability of a false positive in a complete genome scan, whereas
MASCOT produces a score that describes the probability of
false-positive for each protein considered.
The system consists of a client-server pair with a UNIX
command-line interface. The server performs the in silico di-
gestion and keeps the resulting database in memory, obviating
the recomputation of the genome digest over multiple MS
analyses. Each client receives a peptide mass list, connects to the
server for processing, and outputs the results. The client gener-
ates a formatted HTML file displaying the clusters for the 10
highest-scoring windows, with matched fragments highlighted in
different colors according to the reading frame in which they are
found to facilitate visual identification of transframe events. The
entire region’s score and the highest score for any contained
window of size w are reported. The significance is calculated as
a function of the latter, maximal fixed window-size score.
Server parameters include the number of missed cleavages to
be calculated, window size, a directory containing all FASTA-
formatted genome sequences, and whether to use average or
mono-isotopic masses. Client parameters include the file con-
taining a peptide mass list, the host name of the server, the tcp
port number, % mass tolerance, and parameters related to
random trials. The programs currently run on the UNIX com-
mand line of MacOS X, with potential deployment on Linux. We
plan to make a graphical interface accessible to other researchers
via the web. The current prototype code is available free of
charge to nonprofit researchers.
Laboratory Methods
S. cerevisiae Mitochondria. The S. cerevisiae strain used was BY
4743 Diploid, His 3, Leu 2, Ura 3. Yeast cultures were grown
in YPGE (1% yeast extract2% bactopeptone2% glycerol2%
ethanol) media at 30°C to an OD600 of 1.0. Mitochondria were
isolated as described (22). Oxyliticase (Enzogenetics, Corvallis,
OR) was used instead of or in addition to Zymolase (ICN) in
some preparations. Mitochondria were lysed by sonication in 50
mM 3-cyclohexylamino-1-propane sulfonic acid (CAPS), pH
10.5. Polyethyleneimine was added to a final concentration of
0.1% to precipitate nucleic acids. After a 20-min incubation at
4°C, samples were centrifuged at 60,000 rpm for 2 h in a Beckman
TL-100 centrifuge (TLA 100.3 rotor).
Cleared mitochondrial lysate was separated on a PerSeptive
Biosystems (Framingham, MA) BioCad Sprint HPLC system
with a 4.6 
 100 mm column packed with Poros 20 HQ (strong
anion exchange) media (PerSeptive Biosystems). The running
buffer was 50 mM CAPS, pH 10.5, and proteins were eluted from
the column with 0 to 1 M NaCl gradient over five column
volumes. Collected fractions were further separated on the same
system with Poros 20 R2 (reversed phase) media. The running
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buffer was 0.1% trif luoroacetic acid15% acetonitrile, and pro-
teins were eluted from the column with a 15–45% acetonitrile
gradient. Fractions were lyophilized then digested with modified
sequencing grade trypsin (Promega) as per vendor instructions.
Molecular weights of proteins and peptides were determined
by using positive-ion electrospray MS on a Quattro-II mass
spectrometer (Micromass). ESI generates a series of multiply
charged molecular ions from which mass assignments are derived
for each protein or peptide. Molecular masses for peptides were
determined by manually deisotoping and deconvolving the mass-
to-charge (mz) spectra.
E. coli. Data from an analysis of selected proteins from two strains
of E. coli, CSH 142 and CSH 156, was provided by workers at
Kendrick Labs (Madison, WI), who performed 2D electrophore-
sis by using the methods described (23). A brief summary follows.
Proteins were added as standards to the gel: myosin (220 kDa),
phosphorylase A (94 kDa), catalase (60 kDa), actin (43 kDa),
carbonic anhydrase (29 kDa), and lysozyme (14 kDa) (Sigma).
Spots with large differences in expression level between the two
strains were selected for analysis. The bandsspots were cut and
digested by using 0.06 g of modified trypsin (sequencing grade,
Roche Molecular Biochemicals) in 13–15 l of 0.025 M Tris, pH
8.5. The tubes were placed in a heating block at 32°C and left
overnight. Peptides were extracted with 2 
 50 l of 50%
acetonitrile2% trif luoroacetic acid and then the combined
extracts were dried and resuspended in matrix solution, 4-
hydroxy--cyanocinnamic acid in 50% acetonitrile0.1% trif lu-
oroacetic acid with two standards, angiotensin and bovine
insulin. An aliquot of 0.7 ml was spotted onto the sample plate,
completely dried, and washed twice with water. A PerSeptive
Voyager DE-RP MALDI–time-of-f light mass spectrometer was
used to analyze digest samples in the linear or reflector mode
(Applied Biosystems). The National Center for Biotechnology
Information andor GenPept databases were searched by the
service lab by using PROFOUND (http:prowl.rockefeller.edu
cgi-binProFound), MS-FIT (http:prospector.ucsf.edu), and
PEPTIDENT (http:us.expasy.orgtoolspeptident.html).
Results
Data from ESI-MS analysis of S. cerevisiae mitochondrial pro-
teins and MALDI-MS analysis of E. coli proteins were used to
test the GFS system. We rejected the use of synthetic data for
reasons similar to those cited by Perkins et al. (6), e.g., because
the real experimental factors that play into the observed data are
not well enough understood to be modeled as required for the
generation of realistic synthetic data.
On the other hand, the absence of authoritative identifications
for the analyzed proteins requires that we evaluate performance
by comparing our results with those of other algorithms. Our
performance assessment is based on comparisons with both
PEPTIDENT (4) and MASCOT (6), well recognized tools used for
the data analysis in our yeast proteome project. In most cases
both of the programs were used for comparison; however, there
are a few for which only MASCOT was used, because later in the
S. cerevisiae project that became the default analysis tool. For
MASCOT analyses in our proteome project, proteins with a match
score 70 were considered significant identifications.
As opposed to the single protein samples typically produced by
2D gel separation, our yeast mitochondrial samples contain
multiple proteins, a result of the method of HPLC separation
used. The regular presence of multiple proteins imposes certain
constraints on the system. For example, it greatly complicates the
consideration of mutually exclusive possibilities required to
develop a Bayesian formula for probability assessment of iden-
tifications as was done in PROFOUND (5). An alternative is to base
comparisons on the distribution of randomized data, as we have
done here. The increased number of peptides in a multiprotein
analyte further increases the background noise level, making
matches more difficult to distinguish.
To establish the significance levels of scores we performed
multiple repetitions of experiments by using randomized mass
lists of varying lengths. For S. cerevisiae, 1,000 repeat trials were
performed, with lists of length 20–100 in increments of five. An
example histogram of scores produced from one such set of trials
is shown in Fig. 3, which is published as supporting information
on the PNAS web site. The process was repeated for E. coli with
lists of 20–50 random masses, incremented by five. The program
keeps a summary histogram plotting scores against the number
of w  500-nt windows achieving each score. A plot of the Ps 
0.001 (maximum scores) and Ps  0.05 values versus mass-list
size is in Fig. 2. The curves show a close to linear relationship
between the number of masses input and confidence thresholds,
with the Ps  0.05 varying more smoothly because of the higher
quantity of data available to establish it.
Twenty-two samples were chosen for the comparative perfor-
mance analysis, 18 from yeast and four from E. coli. The yeast
samples were selected at random from the larger pool of those
available. The program was run with each mass list, and results
were manually parsed, with the top two scoring clusters consid-
ered in each case. The score for each cluster region was
compared with the null hypothesis to compute the P value by
interpolating between the two nearest mass-list sizes (increments
of five).
The genome position of each identified cluster was compared
with ORF annotations for yeast or E. coli. An ORF encompass-
ing and in-frame with the cluster region was noted as a match.
For the yeast searches, an in-house program was used to match
positions to annotated ORFs in a mid-2001 download from
the Saccharomyces Genome Database (http:genome-www.
stanford.eduSaccharomyces). E. coli searches were performed
manually against the National Center for Biotechnology Infor-
mation database by using the summary data at www.ncbi.nlm.
nih.govcgi-binEntrezaltik?gi115&dbGenome (late
2001). The parameters for all reported experiments were w 
500, %  0.05, and b  3, with monoisotopic peptide masses
used for the yeastESI experiments and average peptide masses
for the E. coliMALDI experiments. Fig. 4, which is published
as supporting information on the PNAS web site, is an illustra-
tion of typical output from the program.
Fig. 2. Confidence levels established by sets of random mass-list trials against
the S. cervisiae whole-genome digest. }, Top scores in 1,000 trials, equating to
Ps  0.001. ■ , The scores above which Ps  0.05. The dotted and solid lines are
a linear regression for the two data sets, shown along with their equations and
R values.


















Seventeen of the 22 samples had a top-scoring cluster region
with significance Ps  0.05. Of the five not within this threshold,
four had top-scoring clusters falling in ORFs identified in the
database as mitochondrially localized proteins; the remaining
region did not correspond to an obvious ORF. The top-scoring
GFS-identified ORF was also top scoring for one of the other
programs in 16 cases, including one case where MASCOT and GFS
agreed that no significant matches were present. When counting
agreement between either first- or second-place significant
protein matches, the GFS and MASCOTPEPTIDENT corrobora-
tion increases to 19 samples or 86%. Table 1 shows six repre-
sentative results, including two disagreements and one where the
second-place identification was corroborated. The disagree-
ments provide insights into differences between the algorithms.
Sample 2378 F9 with GFS score 121 (Ps  0.004) mapped to an
ORF for the mitochondrial precursor of alcohol dehydrogenase
(ADH3), whereas the other programs identified the sample
protein as phosphoglycerate kinase (PGK). Given the high
significance and mitochondrial localization of ADH3, it is likely
that GFS correctly identified a different component of the
sample than the other programs. GFS also corroborated the
PGK identification, it being the second top-scoring region found.
Another analyte was identified by GFS as PET127, a protein
annotated in GenBank as a component of the mitochon-
drial translation system. For this sample neither MASCOT nor
PEPTIDENT found anything significant. It appears from the GFS
program output that only a small, 10-kDa portion of the
protein was present during tryptic digestion, which would ac-
count for the poor significance score. It would also explain the
difficulty MASCOT had with this, because this is a small piece of
a large 93-kDa protein predicted in the ORF database. In
another case, GFS identified POM152 (Ps  0.03), whereas
MASCOT found nothing significant and PEPTIDENT had a weak
match for ABC1. As with the previous case, the parent protein
predicted by the database (Saccharomyces Genome Database) is
large: 151 kDa. This finding highlights an advantage of position-
based peptide matching. It is likely that a portion of analyzed
proteins has undergone in vivo proteolysis, causing incomplete
peptide coverage. Because the peptide coverage, when averaged
over a large protein, will be low, such cases can confound
searches that rely on ORF or protein annotation. With the
genome-based positional scanning of GFS, parent protein size
does not directly affect its performance unless a protein is much
smaller in size than the window used for analysis.
Table 2 illustrates the detection of multiple proteins within a
sample containing a large number of peptides (88 total). To
calculate the significance for each match region we remove from
the experimental mass list all masses matched to a higher-scoring
region and not contained in the current region and calculate the
significance corresponding to the score and this new number of




















(score) GFS ID Notes
2378 E2 YeastESI 41 0.001 112 Yes Chr XII 734881–
736039 (rev)
ACO1 ACO1 (90) ACO1 Aconitate hydratase
WT-5 E. coliMALDI 29 0.001 88 Yes 849492–850188 ompX NA ompX Outer membrane protein X
2378 F9 YeastESI 61 0.004 121 No Chr XIII 435350–
436343
PGK PGK (125) ADH3 GFS second-scoring hit is PGK,
S  82
2681 E1 YeastESI 60 0.028 102 No Chr XIII, 529500–
530700
ABC1 Nothing POM152 Parent is 151 kDA, may be reason
MASCOTPEPIDENT didn’t find it
2681 D11 YeastESI 60 0.208 84 Yes Chr XV 387289–
387874 (rev)
Q12452 Nothing Nothing —
2838 C3 YeastESI 47 0.317 63 No Chr XV 363100–
364100
Nothing Nothing ?PET127? Though low significance, PET127
is large, putative mitochondrial
protein
Shown are the sample, organism, MS method, and number of masses collected for program input. The significance (P value), calculated by Ps, and top-ranked
score found by GFS for the sample follow. The next columns indicate whether GFS and one of the programs agreed, the chromosomal location of the region
identified by GFS (rev denotes the reverse strand), and the identification results produced by PEPTIDENT, MASCOT, and GFS, followed by notes regarding the sample.
Table 2. Results for the top five scoring clusters in a GFS analysis of a sample containing multiple proteins
Sample ID
GFS


















88 12 142 0.032 2 (95) 1




77 14 138 0.009 3 (61) —
2667 E10(3) YBR271W Hypothetical ORF II 745051–745987 67 13 105 0.064 — —
2667 E10(4) YPL245W Hypothetical ORF XVI 86398–86875 52 13 104 0.002 — —
2667 E10(5) ATP2 F(1)F(0)-ATPase complex
beta subunit,
mitochondrial
X 647391–647970 37 10 103 0.002 3 (61) 6
The mass spectrometer output listed 88 masses. To calculate significance values we removed from the experimental mass list all masses matched to
higher-scoring regions and not contained in the region currently being considered, and calculated the significance corresponding to the score and this new
number of masses by using the probability regression in Fig. 2. Shown is the identified ORF, along with the ranking of this identification compared to MASCOT
and PEPTIDENT ranking for the same identification.
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masses. The rationale for this is its equivalency to removing the
masses previously matched and rerunning the scan. GFS is
unique among MS search algorithms for its ability to establish
significance levels based only on the number of masses input.
The use of a fixed window size for scanning simplifies the
detection of multiple proteins and assessment of their signifi-
cance in a single-pass analysis.
Identifications for all four E. coli samples matched the stan-
dard results, and all of them had GFS scores with significance
Ps  0.001. The stronger E. coli results are likely caused by the
samples each having only one protein and by higher mass
accuracy from both the instrument and data analysis methods.
The ESI process generates ions with multiple charge states,
whereas MALDI typically produces singly charged ions. For the
ESI data, we lacked appropriate software to perform deconvo-
lution of multiply charged spectra into straight mass spectra; our
manual deconvolution may have been less accurate. Given the
lower quality of these data and the relaxed match criteria used
(500 ppm), the performance of GFS on the ESIyeast data is
promising.
Discussion
The empirically determined working parameter sets sufficed for
practical operation on these distinct data sets but should be
optimized by further experimentation to match the properties of
the experimental equipment used. For example, mass tolerance
should be decreased for higher mass accuracy data, effectively
reducing the number of random hits. Optimization of window
size is potentially complex, depending on protein size, gene
composition, and the local configuration of matched fragments.
If spliced genes are analyzed, the window size may have to be
much larger, with a second, smaller window scan to identify
putative exons.
We performed an experiment to investigate the extent of the
random backdrop for large mammalian genomes. We repeated
1,000 queries with randomly generated 41- and 61-length mass
lists against the in silico digest of human chromosome XIV,
comprising 135th of the human genome. The background from
this experiment should be roughly equivalent to scanning the
entire genome 28 times. The maximum score for 41-mass lists
was 107, and for 61-mass lists was 134, indicating that a real
match scoring above those thresholds would have a significance
value of less than 128  0.04. Our yeast sample (2378 E2) that
had a 41-mass input list produced a score of 114, which for yeast
is a Ps value 0.001, and for a genome of human size and
composition would still have significance 0.04. A 61-mass
sample that had a Ps  0.004 for yeast would have a Ps  0.13
if matched against a human-sized genome. These data indicate
that scanning a much larger genome is statistically feasible.
Improved MS data, allowing reduction of the tolerance from the
present 500 ppm to 50 ppm, should provide a proportional
10-fold reduction in the random backdrop, improving the like-
lihood of success. However, the identification of proteins con-
sisting of multiple exons remains a considerable challenge that
has not yet been addressed.
Although our implementation is a proof-of-principle proto-
type, we have obtained interesting results contributing useful
information to our research of yeast mitochondrial proteins. In
application to a less-annotated genome than yeast, this method
could contribute to the identification of proteins for which the
database representation is not complete. Potential future en-
hancements include the automatic assignment of probability
values from the regression of random trials, integration with
ORF databases for automatic output of the ORF covering any
high scoring cluster, and a web-based interface. We are opti-
mizing the code for high-throughput analysis on modern vector
processors and plan to deploy the system to provide concurrent
search of multiple mass lists and several genomes.
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